肿瘤微环境
重编程
生物
癌细胞
癌症
核糖核酸
肿瘤进展
癌症研究
细胞生物学
细胞外
细胞
肿瘤细胞
基因
遗传学
作者
Ying Qing,Wu Dong,Xiaolan Deng,Jianjun Chen,Rui Su
标识
DOI:10.1007/978-3-031-45654-1_1
摘要
RNA modifications have recently been recognized as essential posttranscriptional regulators of gene expression in eukaryotes. Investigations over the past decade have revealed that RNA chemical modifications have profound effects on tumor initiation, progression, refractory, and recurrence. Tumor cells are notorious for their robust plasticity in response to the stressful microenvironment and undergo metabolic adaptations to sustain rapid cell proliferation, which is termed as metabolic reprogramming. Meanwhile, cancer-associated metabolic reprogramming leads to substantial alterations of intracellular and extracellular metabolites, which further reshapes the tumor microenvironment (TME). Moreover, cancer cells compete with tumor-infiltrating immune cells for the limited nutrients to maintain their proliferation and function in the TME. In this chapter, we review recent interesting findings on the engagement of epitranscriptomic pathways, especially the ones associated with N6-methyladenosine (m6A), in the regulation of cancer metabolism and the surrounding microenvironment. We also discuss the promising therapeutic approaches targeting RNA modifications for anti-tumor therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI